2023 - Research.com Medicine in Germany Leader Award
Peter Riederer mostly deals with Internal medicine, Endocrinology, Parkinson's disease, Neuroscience and Substantia nigra. His studies link Phosphorylation with Internal medicine. His biological study deals with issues like Human brain, which deal with fields such as Receptor.
His Parkinson's disease research is multidisciplinary, incorporating elements of Dopaminergic and Central nervous system disease, Degenerative disease. He interconnects Alzheimer's disease, Disease and NMDA receptor in the investigation of issues within Neuroscience. His Substantia nigra study combines topics in areas such as Oxidative stress and Ferritin.
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Parkinson's disease, Neuroscience and Pharmacology. Endocrinology is frequently linked to Human brain in his study. His Parkinson's disease study integrates concerns from other disciplines, such as Bioinformatics and Degenerative disease.
His Neuroscience research includes themes of Glutamate receptor, Psychosis and Neurodegeneration. He has included themes like NMDA receptor, Selegiline, Monoamine oxidase B, Monoamine oxidase and Rasagiline in his Pharmacology study. His Disease research incorporates elements of Neurology and Immunology.
Parkinson's disease, Disease, Internal medicine, Neuroscience and Neurology are his primary areas of study. His study in Parkinson's disease is interdisciplinary in nature, drawing from both Dopamine and Pharmacology. In his study, Neurotrophic factors is strongly linked to Neuroprotection, which falls under the umbrella field of Dopamine.
His Disease research is multidisciplinary, incorporating perspectives in Rat model and Bioinformatics. The Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Oncology. His studies in Neuroscience integrate themes in fields like Neurodegeneration and Parkinsonism.
His primary areas of study are Parkinson's disease, Disease, Neurology, Internal medicine and Neuroscience. His work carried out in the field of Parkinson's disease brings together such families of science as Dopamine and Pharmacology. His work on Alzheimer's disease as part of general Disease research is often related to Clinical neurology, thus linking different fields of science.
Internal medicine is closely attributed to Endocrinology in his work. He is interested in Oxidative stress, which is a branch of Endocrinology. His work investigates the relationship between Neuroscience and topics such as Neurodegeneration that intersect with problems in Memory impairment.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Allelic Variation of Human Serotonin Transporter Gene Expression
A Heils;A Teufel;S Petri;G Stöber.
Journal of Neurochemistry (2002)
Iron, brain ageing and neurodegenerative disorders
Luigi Zecca;Moussa B. H. Youdim;Peter Riederer;James R. Connor.
Nature Reviews Neuroscience (2004)
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains.
Peter Riederer;Emin Sofic;Wolf-Dieter Rausch;Bruno Schmidt.
Journal of Neurochemistry (1989)
Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients
Makio Mogi;Minoru Harada;Peter Riederer;Hirotaro Narabayashi.
Neuroscience Letters (1994)
Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients
Doris Blum-Degen;Thomas Müller;Wilfried Kuhn;Manfred Gerlach.
Neuroscience Letters (1995)
Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients
Makio Mogi;Minoru Harada;Tomoyshi Kondo;Peter Riederer.
Neuroscience Letters (1994)
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain.
E. Sofic;P. Riederer;H. Heinsen;H. Beckmann.
Journal of Neural Transmission (1988)
Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease
L. Frölich;D. Blum-Degen;H.-G. Bernstein;S. Engelsberger.
Journal of Neural Transmission (1998)
Organization of the human serotonin transporter gene.
K P Lesch;U Balling;J Gross;K Strauss.
Journal of Neural Transmission (1994)
PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease
Bin Zheng;Zhixiang Liao;Joseph J. Locascio;Kristen A. Lesniak.
Science Translational Medicine (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: